Yahoo Suche Web Suche

Suchergebnisse

1. Suchergebnisse:

1. healthecon.iges.comOptimizing Market Access - HealthEcon

   healthecon.iges.com

   • Im Cache

   HealthEcon, based in Basel, Switzerland, is a consulting firm for Health Technology Assessment, European market access and value strategy for the pharmaceutical industry.

   • Swiss healthcare consulting since 1981

     HealthEcon is one of the most experienced healthcare...

   • Reimbursement of Pharmaceuticals

     The reimbursement of pharmaceuticals in Europe is based on...

2. healthecon.iges.com › about-us › index_engSwiss healthcare consulting since 1981

   healthecon.iges.com › about-us › index_eng

   • Im Cache

   HealthEcon is one of the most experienced healthcare consulting companies in Europe. We are based in Basel, Switzerland, with more than 1100 projects completed since our establishment in 1981. We mainly provide consultation services on pharmaceuticals for the leading European markets

3. healthecon.iges.com › reimbursement › index_engReimbursement of Pharmaceuticals - HealthEcon

   healthecon.iges.com › reimbursement › index_eng

   • Im Cache

   The reimbursement of pharmaceuticals in Europe is based on the requirements of the individual member states. After marketing authorization, national HTA bodies evaluate the additional therapeutic benefit of the new pharmaceutical compared with other new or existing treatments.

4. ch.linkedin.com › company › healthecon-agHealthecon AG | LinkedIn

   ch.linkedin.com › company › healthecon-ag

   Die HealthEcon AG, Basel, (gegründet 1981), ist eines der erfahrensten Beratungsunternehmen im Gesundheitswesen in der medizinischen, epidemiologischen und ökonomischen Bewertung von...

5. www.swissbiotech.org › listing › healthecon-agHealthecon AG – Swiss Biotech

   www.swissbiotech.org › listing › healthecon-ag

   • Im Cache

   HealthEcon provides services on pharmaceuticals for the leading European markets, including reimbursement and pricing analyses, early advice on market access and trial design, appraisal of clinical evidence and healtheconomic assessment, compilation of reimbursement dossiers (e.g. AMNOG)

6. ch.linkedin.com › in › dr-stephan-ruckdäschel-54b5a0122Dr. Stephan Ruckdäschel – Geschäftsführer – Healthecon AG |...

   ch.linkedin.com › in › dr-stephan-ruckdäschel-54b5a0122

   Managing Director / Strategy & Consulting / Development and Implementation of Market Access and AMNOG Procedures for Pharmaceutical Industries. · Berufserfahrung: Healthecon AG · Ausbildung:...

   • Standort: Healthecon AG

7. www.medinside.ch › post › healthecon-joerg-ruof-roche-hannoverBasel: Neuer CEO bei HealthEcon - Medinside

   www.medinside.ch › post › healthecon-joerg-ruof-roche-hannover

   • Im Cache

   20. Dez. 2016 · Der Mediziner Jörg Ruof wird zum 1. Januar 2017 neuer Chief Executive Officer (CEO) der auf Gesundheitssysteme spezialisierte Beratungsfirma HealthEcon. Dies teilt das Basler Unternehmen mit.